The scientific rediscovery of an ancient Chinese herbal medicine: Cordyceps sinensis Part I

被引:382
|
作者
Zhu, JS
Halpern, GM
Jones, K
机构
[1] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA USA
[2] Shanghai Med Univ, Shanghai, Peoples R China
[3] Univ Calif Davis, Davis, CA USA
[4] Armana Res Inc, Gibsons, BC, Canada
关键词
D O I
10.1089/acm.1998.4.3-289
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
This review presents Cordyceps sinensis (Berk.) Sacc., a fungus highly valued in China as a tonic food and herbal medicine. The extant records show the continued use of C. sinensis is now centuries old. The major chemical, pharmacological, and toxicological studies on C. sinensis and the various derived, cultured, fermented mycelial products currently in use are reviewed from the English and Chinese literature. preclinical in vitro and in vivo studies and clinical blinded or open-label trials in to date over 2000 patients are reviewed. These studies show the main activities of the fungus in oxygen-free radical scavenging, antisenescence, endocrine, hypolipidemic, antiatherosclerotic, and sexual function-restorative activities. The safety of the fungus, its effects on the nervous system, glucose metabolism, the respiratory, hepatic, cardiovascular, and immune systems, immunologic disease, inflammatory conditions, cancer, and diseases of the kidney will be reviewed in the second part of this article to be published in the winter issue of this journal.
引用
收藏
页码:289 / 303
页数:15
相关论文
共 50 条
  • [41] Reparative properties of the traditional Chinese medicine Cordyceps sinensis (Chinese caterpillar mushroom) using HT29 cell culture and rat gastric damage models of injury
    Marchbank, Tania
    Ojobo, Ehighale
    Playford, Christopher J.
    Playford, Raymond J.
    BRITISH JOURNAL OF NUTRITION, 2011, 105 (09) : 1303 - 1310
  • [42] Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis
    Lee, David Y. W.
    Li, Qing Y.
    Liu, Jing
    Efferth, Thomas
    PHYTOMEDICINE, 2021, 80
  • [43] Chinese medicine as vegetative systems biology. Part I: therapeutic methods
    Greten, H. J.
    HNO, 2011, 59 (12) : 1160 - 1164
  • [44] Gastrodin: An ancient Chinese herbal medicine as a source for anti-osteoporosis agents via reducing reactive oxygen species
    Huang, Qiang
    Shi, Jun
    Gao, Bo
    Zhang, Hong-Yang
    Fan, Jing
    Li, Xiao-Jie
    Fan, Jin-Zhu
    Han, Yue-Hu
    Zhang, Jin-Kang
    Yang, Liu
    Luo, Zhuo-Jing
    Liu, Jian
    BONE, 2015, 73 : 132 - 144
  • [45] Ancient Chinese Medicine Herbal Formula Huanglian Jiedu Decoction as a Neoadjuvant Treatment of Chemotherapy by Improving Diarrhea and Tumor Response
    Chan, Yau-Tuen
    Cheung, Fan
    Zhang, Cheng
    Fu, Bowen
    Tan, Hor-Yue
    Norimoto, Hisayoshi
    Wang, Ning
    Feng, Yibin
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [46] A polysaccharide isolated from Cordyceps sinensis, a traditional Chinese medicine, protects PC12 cells against hydrogen peroxide-induced injury
    Li, SP
    Zhao, KJ
    Ji, ZN
    Song, ZH
    Dong, TTX
    Lo, CK
    Cheung, JKH
    Zhu, SQ
    Tsim, KWK
    LIFE SCIENCES, 2003, 73 (19) : 2503 - 2513
  • [47] Evolution of MHC class I genes in two ancient fish, paddlefish (Polyodon spathula) and Chinese sturgeon (Acipenser sinensis)
    Wang, Dengqiang
    Zhong, Lei
    Wei, Qiwei
    Gan, Xiaoni
    He, Shunping
    FEBS LETTERS, 2010, 584 (15) : 3331 - 3339
  • [48] Chinese medicine users in the United States part I: Utilization, satisfaction, medical plurality
    Cassidy, CM
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 1998, 4 (01) : 17 - 27
  • [49] Effects of Zaizhang-I,A Traditional Chinese Herbal Medicine,on Hematopoietic Recovery from Radiation Injury In Mice
    杨明炜
    何美冬
    李鸣真
    Current Medical Science, 1994, (04) : 224 - 226
  • [50] Recent development of antitumor agents from Chinese herbal medicines; Part I. Low molecular compounds
    Tang, WC
    Hemm, I
    Bertram, B
    PLANTA MEDICA, 2003, 69 (02) : 97 - 108